Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 3

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 3 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 3 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Phosphodiesterase inhibitors in inflammatory bowel disease

Pooneh Salari & Mohammad Abdollahi

Pages: 261-264

Published online: 06 Feb 2012

AbstractforPhosphodiesterase inhibitors in inflammatory bowel disease | Full Text | References | PDF (164.7 KB)

2405 Views
31 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea])

Osmond J D'Cruz, Sanjive Qazi, Seang Yiv & Fatih M Uckun

Pages: 265-279

Published online: 01 Feb 2012

AbstractforA novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea]) | Full Text | References | PDF (376.5 KB)

169 Views
9 CrossRef citations
0Altmetric

Review Article

Novel targeted therapies in head and neck cancer

Mariana B A Ferreira, João Paulo S N Lima & Ezra E W Cohen

Pages: 281-295

Published online: 12 Jan 2012

AbstractforNovel targeted therapies in head and neck cancer | Full Text | References | PDF (334.8 KB)

462 Views
11 CrossRef citations
0Altmetric

Review Article

Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis

John A Morren MD MBBS (Hons) & Nestor Galvez-Jimenez MD MSc MHSA FACP

Pages: 297-320

Published online: 06 Feb 2012

AbstractforCurrent and prospective disease-modifying therapies for amyotrophic lateral sclerosis | Full Text | References | PDF (314.7 KB)

1227 Views
30 CrossRef citations
0Altmetric

Review Article

The therapeutic potential of GPR119 agonists for type 2 diabetes

Takahide Ohishi PhD & Shigeru Yoshida PhD

Pages: 321-328

Published online: 03 Feb 2012

AbstractforThe therapeutic potential of GPR119 agonists for type 2 diabetes | Full Text | References | PDF (228.5 KB)

1586 Views
78 CrossRef citations
0Altmetric

Review Article

A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases

Saumya Pandey, Satish K Srivastava & Kota V Ramana PhD

Pages: 329-339

Published online: 28 Jan 2012

AbstractforA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases | Full Text | References | PDF (324.6 KB)

170 Views
29 CrossRef citations
0Altmetric

Review Article

Development of novel CXCR4-based therapeutics

Amnon Peled, Ori Wald & Jan Burger

Pages: 341-353

Published online: 28 Jan 2012

AbstractforDevelopment of novel CXCR4-based therapeutics | Full Text | References | PDF (235.3 KB)

1127 Views
70 CrossRef citations
0Altmetric

Review Article

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

Eric S Winer MD, Randall R Ingham & Jorge J Castillo

Pages: 355-361

Published online: 03 Feb 2012

AbstractforPCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies | Full Text | References | PDF (227.1 KB)

1659 Views
29 CrossRef citations
0Altmetric

Drug Evaluations

Article

Obatoclax mesylate: pharmacology and potential for therapy of hematological neoplasms

Jamal Joudeh MD & David Claxton MD

Pages: 363-373

Published online: 11 Feb 2012

Abstractfor Obatoclax mesylate: pharmacology and potential for therapy of hematological neoplasms | Full Text | References | PDF (317.4 KB)

313 Views
39 CrossRef citations
0Altmetric

Article

Update on alisporivir in treatment of viral hepatitis C

Robert Flisiak, Jerzy Jaroszewicz, Iwona Flisiak & Tadeusz Łapiński

Pages: 375-382

Published online: 08 Feb 2012

AbstractforUpdate on alisporivir in treatment of viral hepatitis C | Full Text | References | PDF (209.4 KB)

380 Views
42 CrossRef citations
0Altmetric

Article

Danusertib, an aurora kinase inhibitor

Hielke J Meulenbeld MD, Ron HJ Mathijssen, Jaap Verweij, Ronald de Wit & Maja JA de Jonge

Pages: 383-393

Published online: 13 Jan 2012

Abstractfor Danusertib, an aurora kinase inhibitor | Full Text | References | PDF (328.9 KB)

859 Views
51 CrossRef citations
0Altmetric

Article

Elvitegravir: a once-daily inhibitor of HIV-1 integrase

Todd Wills MD & Vivian Vega MD

Pages: 395-401

Published online: 10 Feb 2012

Abstractfor Elvitegravir: a once-daily inhibitor of HIV-1 integrase | Full Text | References | PDF (218.4 KB)

594 Views
38 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.3, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?